drugset / Trial / NCT00541671

Prevention of Narcotic-Induced Nausea

NCT00541671 ↗

Terminated 25 enrolled Christiana Care Health Services
RandomizedParallel-groupDouble-blindPrevention

Summary

We are doing this study to find out if extra medicine is needed to avoid the chance of nausea sometimes linked to narcotic pain medicine (for example, morphine, dilaudid, fentanyl). Some doctors always give medicine to prevent the possible side effect of nausea, while others do not. We are looking to see if this extra medicine is helpful in preventing nausea. The goal is to screen all patients with pain and enroll enough subjects to reach our goal of 164 evaluable study participants.

Timeline

Start
2007-02
Primary completion
2009-09
Completion
2009-11

Outcome

Outcome not reported

Stopped (Enrollment): “Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Promethazine Small molecule 6.25 mg Intravenous

Indications

No indication recorded.